RxAnte has filed a notice of an exempt offering of securities to raise $25,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, RxAnte is raising $25,000,000.00 in new funding. Sources indicate as part of senior management Chief Operating Officer, Peter Aldrich played a key role in securing…